House Oversight Chairman Elijah Cummings (Md.) isn’t the only newly empowered Democrat with his eyes on drug makers. Rep. Diana DeGette of Colorado, the newly minted chair of the Energy and Commerce Committee’s oversight arm, is also planning to haul industry CEOs before her own panel, she said Wednesday at a briefing with reporters.
Trending:
Rep. DeGette, newly atop an oversight subcommittee, promises to grill drug industry CEOs and investigate insulin makers